Defunct Company
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
260
NCT04257370
Kerecis Omega3 Wound Plus SOC vs. SOC Alone in Treating Severe Diabetic Foot Ulcers and Forefoot Amputations
Phase: N/A
Role: Collaborator
Start: Jul 9, 2020
Completion: Nov 25, 2022